Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.10
Delayed Data
As of Apr 24
 +0.214 / +2.71%
Today’s Change
4.71
Today|||52-Week Range
9.24
+8.05%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close7.89
Today’s open7.85
Day’s range7.85 - 8.10
Volume770
Average volume (3 months)7,656
Market cap$75.8M
Dividend yield--
Data as of 3:23pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-26.14%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16,502.46%
P/E ratioNM
Price/Sales41.26
Price/Book9.21

Competitors

 Today’s
change
Today’s
% change
PTBIPlasmaTech Biopharma...+0.15+4.13%
ENZNEnzon Pharmaceutical...+0.18+11.69%
OCRXOcera Therapeutics I...+0.08+2.10%
MSTXMast Therapeutics In...+0.01+1.03%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$1.7M
Annual profit (last year)-$10.1M
Net profit margin-609.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers